Vascular Biogenics Ltd. logo
Vascular Biogenics Ltd. VBLT

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Vascular Biogenics Ltd. DSO Ratio 2011-2026 | VBLT

Annual DSO Ratio Vascular Biogenics Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
114 4.4 K 45.4 127 133 - 65.3 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.4 K 45.4 815

Quarterly DSO Ratio Vascular Biogenics Ltd.

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
8.37 K 16.8 K - - - - - - - 74.7 - - - 1.48 - - - 52.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
16.8 K 1.48 5.07 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Amgen Amgen
AMGN
81.2 $ 350.13 2.98 % $ 188 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
55.7 $ 12.73 3.33 % $ 3.99 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.48 8.82 % $ 394 M britainBritain
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.57 5.59 % $ 3.13 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.82 1.6 % $ 9.19 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.68 4.28 % $ 16.8 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.05 0.66 % $ 6.64 B israelIsrael
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Cerus Corporation Cerus Corporation
CERS
47 $ 1.93 4.62 % $ 368 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
147 - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
52.1 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
3.66 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
56.5 - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
559 $ 1.73 3.59 % $ 203 M usaUSA